In an article in OncLive experts specializing in multiple myeloma mention what they believe to be the top studies presented at the 2021 ASH annual meeting and how their findings have the potential to change clinical practice.
![](https://istopmm.com/wp-content/uploads/2023/03/Sigrun_Th-267x300.jpg)
Prevalence of multiple myeloma precursors revealed for the first time with iStopMM results
Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5%